| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.9M | — |
| R&D Expense | $124.4M | -19.8% |
| SG&A Expense | $53.7M | -2.7% |
| Operating Income | -$171.3M | +19.3% |
| Interest Expense | $9.9M | +36.1% |
| Pre-tax Income | -$176.1M | +18.8% |
| Income Tax | -$25.1M | -3254.2% |
| Net Income | -$151.1M | +30.1% |
| EPS (Basic) | -$1.57 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $128.0M | -67.5% |
| Short-term Investments | $128.5M | — |
| Current Assets | $315.1M | -28.0% |
| Total Assets | $360.2M | -18.9% |
| Current Liabilities | $39.4M | +2.7% |
| Long-term Debt | $75.7M | +8.5% |
| Total Liabilities | $124.0M | +14.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$160.3M | +20.0% |
| Capital Expenditures | $169K | -85.1% |
| Investing Cash Flow | -$127.0M | — |
| Financing Cash Flow | $21.1M | +4520.8% |
| Free Cash Flow | -$160.5M | +20.4% |
| +32.0% |
| EPS (Diluted) | -$1.57 | +32.0% |
| Stockholders' Equity |
| $236.2M |
| -29.7% |